Rebecca Fitzgerald, MD
Procedural Dermatology · Los Angeles, CANPI 1285690321
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $186,941 of the $230,365 with a category attached, or 81.2%. AbbVie accounts for 64.6% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2020 at $59,353 and has fallen 85.1% since, to $8,822 in 2025. Among procedural dermatology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 394 payments — averaging $584.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$149K
- Galderma Laboratories, L.p.$67K
- Revance Therapeutics, Inc.$9K
- Galderma Research & Development, LLC$4K
- Merz North America, Inc.$1K
- Solta Medical, A Division Of Bausch Health US, LLC$135
- plus $287 from 11 others
Across 6 payments — averaging $18,096 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$109K
What the payments were for
- Consulting fees$186,94181%
- Speaking & faculty fees$10,5825%
- Travel & lodging$22,31610%
- Food & beverage$10,5095%
- Education$170%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 271 | $148,801 |
| Galderma Laboratories, L.p. | 69 | $67,459 |
| Revance Therapeutics, Inc. | 14 | $8,803 |
| Galderma Research & Development, LLC | 1 | $3,600 |
| Merz North America, Inc. | 17 | $1,280 |
| Solta Medical, A Division Of Bausch Health US, LLC | 6 | $135 |
| Sun Pharmaceutical Industries Inc. | 3 | $52 |
| Almirall LLC | 2 | $46 |
| Prugen, Inc. Pharmaceuticals | 2 | $33 |
| Mission Pharmacal Company | 2 | $29 |
| Covidien LP | 1 | $28 |
| Aclaris Therapeutics, Inc. | 1 | $20 |
| DUSA Pharmaceuticals, Inc. | 1 | $19 |
| Mayne Pharma Commercial LLC | 1 | $16 |
| LEO Pharma Inc. | 1 | $16 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $14 |
| EPI Health, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX COSMETIC$73,013
- DAXXIFY$8,666
- BOTOX$5,832
- DYSPORT$474
- XEOMIN$278
How this compares
$230,365 in reported general payments places this provider in the 95th percentile of 108 procedural dermatology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other procedural dermatology in Los Angeles
- Jeanette BlackLos Angeles$492K
- Brian DubowLos Angeles$3K
- Sam Khalifianla Mesa$3.5M
- Sabrina FabiSan Diego$3.1M
- Natasha MesinkovskaMission Viejo$499K
- Mitchel GoldmanSan Diego$425K
- Suzanne KilmerSacramento$220K
- Zakia RahmanStanford$181K
- Hrak JalianSanta Monica$160K
- Amelia HausauerCampbell$117K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.